Kai Hübel

Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist

W. Conrad Liles, Hal E. Broxmeyer, Elin Rodger et al. · Blood · 2003 · 715 citations

Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies

Mohamed L. Sorror, Brenda M. Sandmaier, Barry E. Storer et al. · JAMA · 2011 · 315 citations · Full text

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)

Nicolaus Kröger, Simona Iacobelli, Georg‐Nikolaus Franke et al. · Journal of Clinical Oncology · 2017 · 238 citations · Full text

Cell Therapy, Immunology, Myeloid Neoplasia +16

Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation

Rainer Storb, Boglarka Gyurkocza, Barry E. Storer et al. · Journal of Clinical Oncology · 2013 · 210 citations · Full text

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 152 citations · Full text

Lymphoid Neoplasia, End-of-induction Pet Response, Medicine +7